CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL
NYSE · XNYS · stock · Services-Commercial Physical & Biological Research
Chart by TradingView
4/9
Piotroski F — financial health
1.81
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $4.0B | -$144.3M | — | — | $3.2B |
| 2024 | $4.0B | $22.2M | — | — | $3.5B |
| 2023 | $4.1B | $474.6M | — | — | $3.6B |
| 2022 | $4.0B | $486.2M | — | — | $3.0B |
| 2021 | $3.5B | $391.0M | — | — | $2.5B |
| 2020 | $2.9B | $364.3M | — | — | $2.1B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| FOSTER JAMES C | director | 2026-06-05 | Gift | 153,361 | — |
| FOSTER JAMES C | director | 2026-06-05 | Gift | 20,000 | — |
| FOSTER JAMES C | director | 2026-06-05 | Gift | 20,000 | — |
| FOSTER JAMES C | director | 2026-06-05 | Gift | 10,000 | — |
| FOSTER JAMES C | director | 2026-06-05 | Gift | 10,000 | — |
| Girshick Birgit | Chief Executive Officer | 2026-06-05 | Gift | 3,386 | — |
| Girshick Birgit | Chief Executive Officer | 2026-06-05 | Gift | 3,386 | — |
| FOSTER JAMES C | director | 2026-06-05 | Gift | 153,361 | — |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.81 (grey)
- Working capital / assets 0.046
- Retained earnings / assets 0.195
- EBIT / assets 0.004
- Equity / liabilities 0.806
Source: SEC EDGAR filings · CIK 0001100682 · as of 2025-12-27. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.